Total Payments
$21,259
2024 Payments
$550.95
Companies
30
Transactions
554
Medicare Patients
1,611
Medicare Billing
$93,769
Payment Breakdown by Category
Other$11,500 (54.1%)
Food & Beverage$8,186 (38.5%)
Travel$1,544 (7.3%)
Education$28.77 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,500 | 4 | 54.1% |
| Food and Beverage | $8,186 | 541 | 38.5% |
| Travel and Lodging | $1,544 | 5 | 7.3% |
| Education | $28.77 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14,597 | 112 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,823 | 130 | $0 (2024) |
| Amgen Inc. | $1,650 | 97 | $0 (2024) |
| Merck Sharp & Dohme LLC | $522.92 | 32 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $426.68 | 22 | $0 (2024) |
| Amarin Pharma Inc. | $380.66 | 35 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $223.87 | 17 | $0 (2022) |
| Novo Nordisk Inc | $212.99 | 17 | $0 (2024) |
| Allergan Inc. | $193.50 | 20 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $172.13 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $550.95 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($93.68) |
| 2023 | $703.89 | 42 | Janssen Pharmaceuticals, Inc ($182.17) |
| 2022 | $714.87 | 53 | Merck Sharp & Dohme LLC ($182.56) |
| 2021 | $1,262 | 78 | Janssen Pharmaceuticals, Inc ($433.10) |
| 2020 | $916.43 | 62 | Janssen Pharmaceuticals, Inc ($280.03) |
| 2019 | $1,012 | 62 | Amgen Inc. ($351.81) |
| 2018 | $881.18 | 59 | Amgen Inc. ($334.50) |
| 2017 | $15,217 | 169 | Novartis Pharmaceuticals Corporation ($14,109) |
All Payment Transactions
554 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: Cardiovascular | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardio-renal | ||||||
| 10/07/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: DIABETES | ||||||
| 08/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: DIABETES | ||||||
| 08/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.20 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Not Applicable | ||||||
| 06/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: DIABETES | ||||||
| 06/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Not Applicable | ||||||
| 06/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Diabetes | ||||||
| 05/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Oncology | ||||||
| 04/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 420 | 589 | $72,146 | $26,082 |
| 2022 | 9 | 302 | 455 | $60,933 | $22,777 |
| 2021 | 7 | 407 | 629 | $60,897 | $23,089 |
| 2020 | 7 | 482 | 668 | $61,803 | $21,822 |
Total Patients
1,611
Total Services
2,341
Medicare Billing
$93,769
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 125 | $17,500 | $9,711 | 55.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 29 | 30 | $13,500 | $3,661 | 27.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 28 | $5,320 | $3,557 | 66.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 70 | 72 | $12,571 | $3,470 | 27.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 44 | $7,905 | $2,710 | 34.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 58 | 119 | $5,950 | $1,073 | 18.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 98 | 109 | $3,270 | $673.97 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $1,330 | $636.55 | 47.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 24 | 24 | $2,400 | $355.52 | 14.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 24 | 24 | $2,400 | $234.96 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 132 | $18,480 | $10,258 | 55.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 25 | 26 | $11,140 | $3,286 | 29.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 57 | 57 | $10,191 | $2,944 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 18 | $3,420 | $2,288 | 66.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 20 | $5,930 | $1,602 | 27.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 63 | 126 | $6,300 | $1,112 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $1,330 | $699.32 | 52.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 17 | 17 | $1,661 | $271.17 | 16.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 17 | 17 | $1,641 | $180.81 | 11.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 24 | 28 | $840.00 | $136.04 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 142 | $19,880 | $12,161 | 61.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 24 | 25 | $11,250 | $3,079 | 27.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 53 | 54 | $9,738 | $2,810 | 28.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 37 | $3,515 | $1,886 | 53.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 64 | 146 | $7,300 | $1,435 | 19.7% |
About Dr. Mark Geller, MD
Dr. Mark Geller, MD is a Internal Medicine healthcare provider based in Blawnox, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396709069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Geller, MD has received a total of $21,259 in payments from pharmaceutical and medical device companies, with $550.95 received in 2024. These payments were reported across 554 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,500).
As a Medicare-enrolled provider, Geller has provided services to 1,611 Medicare beneficiaries, totaling 2,341 services with total Medicare billing of $93,769. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Blawnox, PA
- Active Since 04/12/2006
- Last Updated 11/19/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396709069
Products in Payments
- ENTRESTO (Drug) $14,524
- XARELTO (Drug) $1,823
- Repatha (Biological) $825.78
- Corlanor (Drug) $756.70
- JARDIANCE (Drug) $420.32
- Vascepa (Drug) $380.66
- VERQUVO (Drug) $332.45
- BELSOMRA (Drug) $177.26
- Kerendia (Drug) $144.45
- BRILINTA (Drug) $140.33
- Ozempic (Drug) $136.92
- BYSTOLIC (Drug) $128.07
- ELIQUIS (Drug) $119.24
- PRALUENT (Drug) $95.53
- INJECTAFER (Drug) $92.68
- FARXIGA (Drug) $83.54
- PRADAXA (Drug) $78.54
- Arcalyst (Drug) $74.94
- LifeVest (Device) $74.28
- LEQVIO (Drug) $72.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.